
Company valuation, historical trends, and peer comparisons.
According to Ono Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.03T. This represents a change of 2.57% compared to the average of 999.44B of the last 4 quarters.
The mean historical Enterprise Value of Ono Pharmaceutical Co., Ltd. over the last ten years is 1.19T. The current 1.03T Enterprise Value has changed -13.69% with respect to the historical average. Over the past ten years (40 quarters), OPHLY's Enterprise Value was at its highest in in the March 2018 quarter at 1.63T. The Enterprise Value was at its lowest in in the March 2025 quarter at 694.92B.
Average
1.19T
Median
1.13T
Minimum
694.79B
Maximum
1.64T
Discovering the peaks and valleys of Ono Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 53.06%
Maximum Annual Enterprise Value = 1.64T
Minimum Annual Increase = -55.46%
Minimum Annual Enterprise Value = 694.79B
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 1.06T | 53.06% |
| 2025 | 694.79B | -32.39% |
| 2024 | 1.03T | -18.62% |
| 2023 | 1.26T | -13.62% |
| 2022 | 1.46T | 5.13% |
| 2021 | 1.39T | 16.63% |
| 2020 | 1.19T | 11.86% |
| 2019 | 1.07T | -35.13% |
| 2018 | 1.64T | 52.69% |
| 2017 | 1.08T | -55.46% |
The current Enterprise Value of Ono Pharmaceutical Co., Ltd. (OPHLY) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
928.62B
5-year avg
1.10T
10-year avg
1.19T
Ono Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Bristol-Myers Squibb Company (166.45B), less than Daiichi Sankyo Company, Limited (5.40T), less than Astellas Pharma Inc. (5.15T), greater than Amgen Inc. (299.50B), less than Eli Lilly and Company (1.38T), greater than Gilead Sciences, Inc. (236.14B), less than Otsuka Holdings Co., Ltd. (6.34T), greater than Biogen Inc. (44.11B), greater than Orion Oyj (14.23B), less than Shionogi & Co., Ltd. (3.02T),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 166.45B | $131.21B | |
| 5.40T | $34.29B | |
| 5.15T | $28.69B | |
| 299.50B | $258.68B | |
| 1.38T | $1.33T | |
| 236.14B | $216.35B | |
| 6.34T | $40.84B | |
| 44.11B | $37.61B | |
| 14.23B | $31.63B | |
| 3.02T | $16.29B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ono Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ono Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Ono Pharmaceutical Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Ono Pharmaceutical Co., Ltd. (OPHLY)?
What is the 3-year average Enterprise Value for Ono Pharmaceutical Co., Ltd. (OPHLY)?
What is the 5-year average Enterprise Value for Ono Pharmaceutical Co., Ltd. (OPHLY)?
How does the current Enterprise Value for Ono Pharmaceutical Co., Ltd. (OPHLY) compare to its historical average?